Development of 14‐gene signature prognostic model based on metastasis for colorectal cancer-Reference-Cited by-同舟云学术

Development of 14‐gene signature prognostic model based on metastasis for colorectal cancer

Published:2022-12-16 Issue:1 Volume:37 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Li Tong¹,Yu Qian¹²,Liu Te¹³,Yang Wenjing¹,Chen Wei¹,Jin Anli¹,Wang Hao¹,Ding Lin¹,Zhang Chunyan¹⁴,Pan Baishen¹,Wang Beili¹⁴,Guo Wei¹²⁴⁵

Affiliation:

1. Department of Laboratory Medicine Zhongshan Hospital, Fudan University Shanghai China

2. Department of Laboratory Medicine, Wusong Branch, Zhongshan Hospital Fudan University Shanghai China

3. Shanghai Geriatric Institute of Chinese Medicine Shanghai University of Traditional Chinese Medicine Shanghai China

4. Department of Laboratory Medicine, Xiamen Branch Zhongshan Hospital, Fudan University Xiamen China

5. Cancer Center, Shanghai Zhongshan Hospital Fudan University Shanghai China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24800

Reference25 articles.

1. Diagnosis and Treatment of Metastatic Colorectal Cancer

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Evidence‐base guideline on management of colorectal liver metastases in the netherlands;Bipat S;Neth J Med,2007

4. Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries